Skip to main content

Table 2 Biochemical profiles at diagnosis (T1) and inclusion (T2)

From: Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3mutation; case report and review of the literature

Parameter

Normal range

Unit

Subject 1

Subject 2

T1

T2

T1

T2

s-Phosphate

M: 0.85-1.65

mmol/L

1.81

2.21

  

F: 0.85-1.50

  

1.6 - 1.84

1.36

s-Calcium

2.15-2.51

mmol/L

2.37

2.36

2.5

2.64

s-iPTH

1.6-6.9

pmol/L

0.8

1.4

NA

5.2

s-Creatinine

M: 60-105

?mol/L

72

78

  

F: 45-90

  

73

61

i-FGF23

26.1-70.21

pg/ml

NA

12

NA

26.8

c-FGF23

10-801

RU/ml

NA

210

NA

120

1,25(OH)2 vit D

50-150

nmol/L

85

87

NA

54

TmP/GFR

> 0.85

mmol/L

1.46

2.07

1.41

1.12

TRP

> 80

%

84

94

88

82.5

  1. 1Reference range valid for the laboratory used for this study.